Berg C, Oeffner A, Schumm-Draeger P-M, Badorrek F, Brabant G, Gerbert B, Bornstein S, Zimmermann A, Weber M, Broecker-Preuss M, Mann K, Herrmann B L
Clinic of Endocrinology, University Hospital of Essen, Germany.
Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):139-44. doi: 10.1055/s-0029-1225611. Epub 2009 Aug 18.
We determined the prevalence of anterior pituitary dysfunction in a multi-centre screening program across five German endocrine centres in patients rehabilitating from TBI (GCS<13).
PATIENTS & METHODS: 246 patients (39+/-14 yrs; 133 males, 12+/-8 months after TBI) underwent a series of baseline endocrine tests with central assessment of TSH, free T4, prolactin, LH, FSH, testosterone (m), estradiol (f), cortisol, GH, and IGF-I. If IGF-I was <-2 SDS dynamic testing was performed. GHD was defined according to BMI-dependent cut-off values for GH response to GHRH+arginine of <4.2, <8.0 and <11.5 ng/ml in obese, overweight and lean subjects, respectively, or <3 micro g/l in ITT. Hypocortisolism was suggested when basal cortisol was <200 nmol/l and confirmed by ITT (peak<500 nmol/l).
In TBI patients some degree of impaired pituitary function was shown in 21% (n=52/246). Total, multiple and isolated deficits were present in 1%, 2% and 18%, respectively. 19% had an IGF-I of <-1 SDS, 9% of <-2 SDS. In 5% GHD was confirmed. 9% had hypogonadism. 4% had hypocortisolism and 1% of patients had confirmed ACTH-deficiency. 12% had TSH-deficiency.
In summary, in this large series carried out on an unselected group of TBI survivors we have found hypopituitarism in every fifth patient with predominantly secondary hypogonadism and hypothyreosis. Regarding somatotrope insufficiency IGF-I is decreased in 50% of GHD patients.
These findings strongly suggest that patients who suffer head trauma should routinely undergo endocrine evaluation.
我们在德国五个内分泌中心开展的一项多中心筛查项目中,对颅脑损伤(GCS<13)康复患者的垂体前叶功能障碍患病率进行了测定。
246例患者(年龄39±14岁;男性133例,颅脑损伤后12±8个月)接受了一系列基线内分泌检查,对促甲状腺激素、游离甲状腺素、催乳素、促黄体生成素、促卵泡生成素、睾酮(男性)、雌二醇(女性)、皮质醇、生长激素及胰岛素样生长因子-I进行了中心评估。若胰岛素样生长因子-I低于-2标准差,则进行动态检测。生长激素缺乏症根据肥胖、超重和消瘦受试者对生长激素释放激素+精氨酸的生长激素反应的BMI相关临界值分别定义为<4.2、<8.0和<11.5 ng/ml,或在胰岛素耐量试验中<3 μg/l。当基础皮质醇<200 nmol/l并经胰岛素耐量试验证实(峰值<500 nmol/l)时提示肾上腺皮质功能减退。
在颅脑损伤患者中,21%(n=52/246)存在一定程度的垂体功能受损。全垂体、多垂体及单垂体功能缺陷分别占1%、2%和18%。19%的患者胰岛素样生长因子-I低于-1标准差,9%低于-2标准差。5%的患者生长激素缺乏症得到确诊。9%的患者性腺功能减退。4%的患者肾上腺皮质功能减退,1%的患者促肾上腺皮质激素缺乏症得到确诊。12%的患者促甲状腺激素缺乏。
总之,在对一组未经选择的颅脑损伤幸存者进行的这项大型研究中,我们发现每五名患者中就有一名存在垂体功能减退,主要为继发性性腺功能减退和甲状腺功能减退。关于生长激素分泌不足,50%的生长激素缺乏症患者胰岛素样生长因子-I降低。
这些发现强烈表明,颅脑外伤患者应常规接受内分泌评估。